Fresenius Medical Care offers a range of dialysers to meet the specific requirements of various therapies and individual patient needs.
Dialysis-related inflammation is fundamental to the onset and progression of cardiovascular disease. Thus, purity and quality of the dialysis fluid is of utmost importance in providing cardioprotective haemodialysis and also contributes to the improvement of anaemia control.1
The routine production of ultrapure dialysis fluid and substitution fluid relies on the implementation of ultrafilters within the fluid pathway of the dialysis machine. Thus, Fresenius Medical Care has developed the DIASAFE®plus filter, which is fitted as standard in the 5008/5008S therapy system and 4008S Next Generation, to ensure an exceptionally high degree of dialysis fluid purity.Reference: